drugset / Trial / NCT07111247
Insights in Endocervical Mucus Secretion
Phase 4
Recruiting
15 enrolled
Oregon Health and Science University
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabNational Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelBasic science
Summary
Single arm interventional study looking at biological outcomes at 4 time points throughout the cycle before and after taking an oral gonadotropin-releasing hormone antagonist (gnRH). Samples of whole blood, endocervical mucus, endocervical biopsy, and vaginal swab will be collected.
Timeline
- Start
- 2026-01-02
- Primary completion
- 2027-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Relugolix | Small molecule | — | Oral |
Indications
No indication recorded.